Zevra Therapeutics, Inc.
(ZVRA - NASDAQ)
9,81 USD
📋 Profilo Aziendale

Zevra Therapeutics, Inc., a rare disease company melding science, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States.

|